Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types.
- Authors
- Dacquino, Claudia; De Rossi, Pietro; Spalletta, Gianfranco
- Year
- 2015
- Journal
- Clinica chimica acta; international journal of clinical chemistry
- PMID
- 25704299
- DOI
- 10.1016/j.cca.2015.02.029
Although diagnosis is a central issue in medical care, in psychiatry its value is still controversial. The function of diagnosis is to indicate treatments and to help clinicians take better care of patients. The fundamental role of diagnosis is to predict outcome and prognosis. To date serious concern persists regarding the clinical utility and predictive validity of the diagnosis system in psychiatry, which is at the most syndromal. Schizophrenia and bipolar disorder, which nosologists consider two distinct disorders, are the most discussed psychiatric illnesses. Recent findings in different fields of psychiatric research, such as neuroimaging, neuropathology, neuroimmunology, neuropsychology and genetics, have led to other conceptualizations. Individuals with schizophrenia or bipolar disorder vary greatly with regard to symptoms, illness course, treatment response, cognitive and functional impairment and biological correlates. In fact, it is possible to find heterogeneous correlates even within the same syndrome, i.e., from one stage of the disorder to another. Thus, it is possible to identify different subsyndromes, which share some clinical and neurobiological characteristics. The main goal of modern psychiatry is to ovethrow these barriers and to obtain a better understanding of the biological profiles underlying heterogeneous clinical features and thus reduce the variance and lead to a homogeneous definition. The translational research model, which connects the basic neuroscience research field with clinical experience in psychiatry, aims to investigate different neurobiological features of syndromes and of the shared neurobiological features between two syndromes. In fact, this approach should help us to better understand the neurobiological pathways underlying clinical entities, and even to distinguish different, more homogeneous, diagnostic subtypes.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Post-GWAS in Psychiatric Genetics: A Developmental Perspective on the "Other" Next Steps. | 2018 | 29227573 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Differentiating bipolar disorder and schizophrenia using sleep EEG power and coherence features: A machine learning approach based on polysomnography. | Zhong Y et al. | β | 2026 | β |
| Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia. | Kelly DL et al. | β | 2026 | β |
| Altered expression of LINC03091 and LINC03090 LncRNAs in bipolar disorder: a case-control study. | Ganji Zeitooni Z et al. | β | 2025 | β |
| Special Issue "Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies". | Tanaka M | β | 2025 | β |
| Abnormal expression of long non-coding RNAs RMRP, CTC-487M23.5, and DGCR5 in the peripheral blood of patients with Bipolar disorder. | Ghamari M et al. | β | 2024 | β |
| Assessment of symptom severity in psychotic disorder patients based on heart rate variability and accelerometer mobility data. | KsiΔ ΕΌek K et al. | β | 2024 | β |
| Lived Experience-Led Research Agenda to Address Early Death in People With a Diagnosis of a Serious Mental Illness: A Consensus Statement. | Fortuna KL et al. | β | 2023 | β |
| Retinal electrophysiology in central nervous system disorders. A review of human and mouse studies. | Constable PA et al. | β | 2023 | β |
| Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles. | Oraki Kohshour M et al. | β | 2022 | β |
| Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data. | Huang Y et al. | β | 2022 | β |
| Cognitive validation of cross-diagnostic cognitive subgroups on the schizophrenia-bipolar spectrum. | Karantonis JA et al. | β | 2020 | β |
| Gut microbiome: An intermediary to neurotoxicity. | Dempsey JL et al. | β | 2019 | β |
| Neurophysiological and Psychological Predictors of Social Functioning in Patients with Schizophrenia and Bipolar Disorder. | Kim Y et al. | β | 2019 | β |
| The Amygdala in Schizophrenia and Bipolar Disorder: A Synthesis of Structural MRI, Diffusion Tensor Imaging, and Resting-State Functional Connectivity Findings. | Ho NF et al. | β | 2019 | β |
| The metabolic basis of psychosis in bipolar disorder: A positron emission tomography study. | Marotta G et al. | β | 2019 | β |
| The Microbiota-Gut-Brain Axis. | Cryan JF et al. | β | 2019 | β |
| Alteration of gray matter microstructure in schizophrenia. | Seitz J et al. | β | 2018 | β |
| Network analysis of specific psychopathology and psychiatric symptoms in patients with eating disorders. | Solmi M et al. | β | 2018 | β |
| Post-GWAS in Psychiatric Genetics: A Developmental Perspective on the "Other" Next Steps. | Dick DM et al. | β | 2018 | β |
| The microbiome, immunity, and schizophrenia and bipolar disorder. | Dickerson F et al. | β | 2017 | β |
| COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients. | ZumΓ‘rraga M et al. | β | 2016 | β |
| Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells. | Watmuff B et al. | β | 2016 | β |